Flenodic Im 25 mg/ml Injection
PDF Leaflet Revision Date: 06 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Initial therapy for inflammatory and degenerative rheumatic disease.
Dosage (summary)
Adults: 75 mg once daily; severe cases: 75 mg twice daily.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may impair fertility.
Key Drug Interactions
- Methotrexate
- Anticoagulants
- Lithium
- Digoxin
Contraindications
- Hypersensitivity to diclofenac
- Gastric or intestinal ulcer
- Severe renal impairment
- Active bleeding disorders
Common side effects
- Gastrointestinal bleeding
- Nausea
- Headache
- Dizziness
Counselling Points
- Use the lowest effective dose for the shortest duration
- Report any unusual abdominal symptoms
- Avoid use with other NSAIDs
Serious warnings
- Risk of gastrointestinal perforation
- Serious skin reactions
- Cardiovascular risks
Important Disclaimer
The Flenodic Im 25 mg/ml Injection professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
